Evidence map›Paper›PMID 41094046›Full record

ArticleScientific reports2025

Evaluation of the antimicrobial and antioxidants potentialities of two Lebanese cultivars of Quinoa (Chenopodium Quinoa Willd.).

Mohamad Omeiri, Walid Meouche, Zainab Alawady, Hoda Yusef, Salwa Abdel Rahman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamad OmeiriDepartment of Biology, Faculty of Arts and Sciences, University of Balamand, Beirut, Lebanon. Mohamad.omeiri@fty.balamand.edu.lb.
Walid MeoucheDepartment of Chemistry, Faculty of Arts and Sciences, University of Balamand, Beirut, Lebanon.
Zainab AlawadyDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, Lebanon.
Hoda YusefDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt.
Salwa Abdel RahmanDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quinoa is a historical food crop that has provided vital sustenance to communities for thousands of years, and its consumption has lately expanded due to its potent antioxidant properties and noteworthy antibacterial activities. The present research investigation was carried out to assess the antibacterial properties of two varieties of quinoa as well as their antioxidant activities. The ethanolic extract of both cultivars (Q12 and Taticaca) displayed moderate inhibition potentials that fall within the range of recognized broad-spectrum antibiotics against S. epidermidis, S. aureus, and E. coli. The quinoa extracts were found to have minimum inhibitory (MIC) and bactericidal (MBC) doses ranging from 375 to 750 µg/mL. The synergistic effects of quinoa extracts and antibiotics were also explored, revealing moderate synergistic interactions. The strains' ultrastructure revealed abnormalities related to the protoplasm and cell wall following treatment with quinoa extracts. These antibacterial and antioxidant activities, as documented in this study, can provide insight into how the two Lebanese cultivars of Quinoa might be used for further hygiene and food product preservation applications.

Indexed as

Anti-Infective AgentsAntioxidantsChenopodium quinoaPlant ExtractsAnti-Bacterial AgentsDose-Response Relationship, DrugEscherichia coliLebanonMicrobial Sensitivity TestsPhytochemicalsStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsPhytochemicalsPlant ExtractsAntimicrobial activityAntioxidant activityMIC/MBCQuinoaTime-kill assay

Identifiers

PMID41094046
PMCPMC12528701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.